Is women's health actually underfunded - and compared with what? For episode 50, I'm going solo to dig into women's health research and funding. Drawing on my background in finance, I separate two questions that usually get blended together: are the conditions affecting women getting enough research attention, and when research does happen, does it give women the answers they need? We look at what the McKinsey 5% figure really measures, NIH funding for women's vs men's health, male-biased animal and cell research, sex as a biological variable, women in clinical trials, disease burden, private investment, and what I'd like to see change. If you've heard the statistics a hundred times and want to get more precise about where the gaps really are, this one is for you. :) Sponsors: The Pelvic People, makers of the Ohnut and the Kiwi. 15% off with code TWTC15 at thepelvicpeople.com/twtc Origin, in-network pelvic floor PT. Get your first month of On Track free with code TWTC at theoriginway.com/twtc Episode sources: https://www.theworldstightestcommunity.com/episode/episode-50-womens-health-research-funding Connect with Mathilde: Instagram: @theworldstightestcommunity Website: theworldstightestcommunity.com Newsletter: https://tinyurl.com/4h4snzzd Support the podcast: https://tinyurl.com/mtxnzhsd Chapters: 00:00:00 Episode 50 Solo, Research and Funding 00:01:22 PubMed, Erectile Dysfunction, Vulvodynia 00:02:25 If Men Had Periods, Reductionism 00:03:41 Getting Precise, Finance Background 00:04:56 Quantifying Underfunding, Data Limits 00:05:29 Two Questions: Attention, Useful Answers 00:07:21 McKinsey 5% Figure, Pipeline vs Funding 00:08:21 Defining Women's Health, Three Groups 00:09:52 Cardiovascular Disease, Sex Differences 00:10:45 Heart Attack Symptoms, Risk Calculators 00:13:16 What Counts as Women's Health Research 00:14:24 McKinsey Revisited, Oncology, 1% 00:15:05 Drug Pipeline vs Total Research Funding 00:16:49 NIH Funding, Women's vs Men's Health 00:17:56 NIH Classification, What It Means 00:19:27 Three Questions on Underfunding 00:21:11 Whose Biology, Male Animals and Cells 00:22:17 2014 Study, 80% Male Animals 00:23:59 Invisible Women, Male as Default 00:24:46 1993 Inclusion Legislation, NIH 00:25:54 Sex as a Biological Variable, 2016 00:26:59 2026 Study: 61% Both Sexes, 44% Analyzed 00:28:11 Averages Hiding Sex Differences 00:29:19 Trial Representation, Cardio, Psychiatry 00:30:45 Representation vs Meaningful Analysis 00:31:51 Zolpidem, Ambien, 2013 FDA Dose Change 00:33:51 Missed Benefits, Male-Only Research 00:34:51 Maternal Health Gaps, Intersectionality 00:36:45 Disease Burden, DALYs, Vulvodynia 00:38:35 NIH Funding vs Disease Burden, 2021 00:40:11 Breast Cancer, Funding Outlier 00:41:32 Private Investment, WEF, BCG Report 00:43:27 Commercial Opportunity, Investor Logic 00:45:01 Pelvic Pain, Underdiagnosis, Investment 00:46:16 What Needs to Change, Long-Term Research 00:47:13 Analyzing Sex Differences 00:47:57 Women in Research Leadership, Authorship 00:49:33 Tool: Questions for Funding News 00:50:05 Takeaways, Nuance in Women's Health 00:51:41 Call for Researchers, Thank You